Get the Stockscreener App
6.9099
4.95%
-0.3601
Nutriband Inc stock is traded at $6.9099, with a volume of 19,464.
It is down -4.95% in the last 24 hours and down -6.12% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$7.27
Open:
$6.77
24h Volume:
19,464
Relative Volume:
0.10
Market Cap:
$78.85M
Revenue:
$2.09M
Net Income/Loss:
$-5.28M
P/E Ratio:
-10.31
EPS:
-0.67
Net Cash Flow:
$-3.64M
1W Performance:
-9.08%
1M Performance:
-6.12%
6M Performance:
+46.71%
1Y Performance:
+175.29%
1-Day Range:
$6.77
$7.225
1-Week Range:
$6.65
$7.75
52-Week Range:
$2.22
$11.78
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
6.935 | 78.85M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.62 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
634.75 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.38 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
112.64 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
Nutriband Inc, Orlando - Florida Trend
Nutriband Inc. to Present at the Emerging Growth Conference on May 25 - ACCESS Newswire
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st - ACCESS Newswire
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May - ACCESS Newswire
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4 - ACCESS Newswire
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology - ACCESS Newswire
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - ACCESS Newswire
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M - ACCESS Newswire
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company - ACCESS Newswire
(NTRB) Long Term Investment Analysis - Stock Traders Daily
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary - ACCESS Newswire
Nutriband Receives Certificate of Registration for - GlobeNewswire
Nutriband secures trademark for drug abuse deterrent tech By Investing.com - Investing.com Nigeria
Nutriband secures trademark for drug abuse deterrent tech - Investing.com
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. - The Manila Times
Can This New Trademark Help Nutriband Capture a $200M Drug Delivery Market? - StockTitan
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3 - ACCESS Newswire
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth - MSN
This Surging Pharma Company Could Hit Profitability by 2027 - Elblog.pl
When Will Nutriband Inc. (NASDAQ:NTRB) Breakeven? - Yahoo Canada Finance
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology - MSN
Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023 - ACCESS Newswire
Nutriband partners with Kindeva for opioid patch development - MSN
Nutriband partners with Kindeva for opioid patch development By Investing.com - Investing.com Nigeria
Short Interest in Nutriband Inc. (NASDAQ:NTRB) Rises By 377.4% - MarketBeat
Nutriband Expands Partnership with Kindeva for Aversa™ - TipRanks
Where are the Opportunities in (NTRB) - Stock Traders Daily
Nutriband Formalizes Development Partnership for Abuse Deterrent Fentanyl Patch With Kindeva - Marketscreener.com
Nutriband and Kindeva Drug Delivery Formalize Exclusive - GlobeNewswire
Nutriband and Kindeva to Co-Develop Aversa Fentanyl Abuse-Deterrent Patch - Contract Pharma
Nutriband And Kindeva Drug Delivery Formalize Exclusive Development Partnership For Aversa Fentanyl Abuse Deterrent Fentanyl Patch - Marketscreener.com
Nutriband, Kindeva Drug Delivery formalize exclusive development partnership - TipRanks
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa - The Bakersfield Californian
Revolutionary Abuse-Deterrent Fentanyl Patch Development: $200M Market Potential - StockTitan
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape - ACCESS Newswire
NutriBand secures patent for abuse deterrent technology By Investing.com - Investing.com Nigeria
NutriBand secures patent for abuse deterrent technology - MSN
Nutriband Secures USPTO Notice for Aversa™ Technology - TipRanks
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board - GlobeNewswire
Noble Capital Markets analysts initates an Outperform rating for Nutriband Inc (NTRB) - Knox Daily
Nutriband Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Upward Trajectory: Nutriband Inc (NTRB) Posts a Gaine, Closing at 7.81 - The Dwinnex
Nutriband secures US patent for abuse deterrent patch - MSN
Nutriband receives notice of allowance for new U.S. Patent for its transdermal abuse deterrent technology; shares rise - MSN
Nutriband Inc trading halted, volatility trading pause - MSN
Nutriband Receives Notice Of Allowance For New U.S. Patent - GlobeNewswire
Game-Changing Patent Win: Nutriband's Abuse-Proof Fentanyl Patch Could Hit $200M in Sales - StockTitan
Nutriband Inc (NTRB) Shares Decline Despite Market Challenges - The News Heater
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology - ACCESS Newswire
Nutriband Inc. (NASDAQ:NTRB) Short Interest Down 24.4% in January - MarketBeat
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.23%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):